{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:53:01Z","timestamp":1792691581157,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.imj.2025.100168","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T19:23:42Z","timestamp":1738783422000},"page":"100168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-8704","authenticated-orcid":false,"given":"Omor","family":"Faruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilhas Ahmed","family":"Jewel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy","family":"Bairagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rasheduzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hindol","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akber Subahan Mahbub","family":"Tuha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayon","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarafat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imj.2025.100168_bib0001","first-page":"280","article-title":"Bacteriophages","author":"Kasman","year":"2023","journal-title":"Brenner\u2019s Encycl. Genet"},{"key":"10.1016\/j.imj.2025.100168_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102240","article-title":"A perfect fit: bacteriophage receptor-binding proteins for diagnostic and therapeutic applications","volume":"71","author":"Klumpp","year":"2023","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0004","doi-asserted-by":"crossref","first-page":"e12435","DOI":"10.15252\/emmm.202012435","article-title":"Biological foundations of successful bacteriophage therapy","volume":"14","author":"Venturini","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.imj.2025.100168_bib0005","doi-asserted-by":"crossref","first-page":"e15272","DOI":"10.7717\/peerj.15272","article-title":"Myriad applications of bacteriophages beyond phage therapy","volume":"11","author":"Garc\u00eda-Cruz","year":"2023","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.imj.2025.100168_bib0006","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001895","article-title":"Current status of clinical trials for phage therapy","volume":"73","author":"Uchechukwu","year":"2024","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000534717","article-title":"The potential of bacteriophage therapy as an alternative treatment approach for antibiotic-resistant infections","volume":"33","author":"Walter","year":"2024","journal-title":"Med Princ Pract"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01249-23","article-title":"Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia","volume":"98","author":"Han","year":"2024","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.imj.2025.100168_bib0009","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/ph16101467","article-title":"Bacteriophages and their host range in multidrug-resistant bacterial disease treatment","volume":"16","author":"Chung","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.imj.2025.100168_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1250848","article-title":"Regulations of phage therapy across the world","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0012","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.1038\/s41598-024-76427-5","article-title":"Current and future directions in bacteriophage research for developing therapeutic innovations","volume":"14","author":"Cui","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/v15010009","article-title":"Application of lytic bacteriophages and their enzymes to reduce saprophytic bacteria isolated from minimally processed plant-based food products-In vitro studies","volume":"15","author":"Shymialevich","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0014","first-page":"153","article-title":"Conditions for the existence of bacteriophage","volume":"15","author":"Campbell","year":"1961","journal-title":"Evolution (N Y)"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/v11060567","article-title":"Understanding and exploiting phage-host interactions","volume":"11","author":"Stone","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.imj.2025.100168_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126746","article-title":"Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents","volume":"248","author":"Grabowski","year":"2021","journal-title":"Microbiol Res"},{"key":"10.1016\/j.imj.2025.100168_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.793135","article-title":"Uses of bacteriophages as bacterial control tools and environmental safety indicators","volume":"12","author":"Rogovski","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1211793","article-title":"Bacteriophage strategies for overcoming host antiviral immunity","volume":"14","author":"Gao","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0019","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/03009734.2014.901444","article-title":"Emergence and spread of antibiotic resistance: setting a parameter space","volume":"119","author":"Mart\u00ednez","year":"2014","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.imj.2025.100168_bib0021","series-title":"Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine","article-title":"Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States","year":"2021"},{"key":"10.1016\/j.imj.2025.100168_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3348695","article-title":"The spread of antibiotic resistance genes in vivo model","volume":"2022","author":"Tao","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0023","article-title":"Microbial resistance","volume":"36","author":"Coleman","year":"2014","journal-title":"Ref Modul Biomed Sci"},{"issue":"11","key":"10.1016\/j.imj.2025.100168_bib0024","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/375081","article-title":"The impact of antimicrobial resistance on health and economic outcomes","volume":"36","author":"Eliopoulos","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.imj.2025.100168_bib0026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/IDR.S234353","article-title":"How phages overcome the challenges of drug resistant bacteria in clinical infections","volume":"13","author":"Taati Moghadam","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0027","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/microorganisms10010046","article-title":"Bacteriophages: combating antimicrobial resistance in food-borne bacteria prevalent in agriculture","volume":"10","author":"Au","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.imj.2025.100168_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.37349\/emed.2024.00217","article-title":"Medicinal and immunological aspects of bacteriophage therapy to combat antibiotic resistance","author":"Noor","year":"2024","journal-title":"Explor Med"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0029","first-page":"83","article-title":"Research progress of phage therapy in orthopedic implant-related infection","volume":"62","author":"Maimaiti","year":"2023","journal-title":"Chin J Surg"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.22207\/JPAM.18.1.49","article-title":"How phage therapy works, its advantages and disadvantages: mini review","volume":"18","author":"Mishra","year":"2024","journal-title":"J Pure Appl Microbiol"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0031","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/ph16121638","article-title":"Phage therapy\u2014Challenges, opportunities and future prospects","volume":"16","author":"Zalewska-Pi\u0105tek","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.imj.2025.100168_bib0032","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/antibiotics13090870","article-title":"A comprehensive review on phage therapy and phage-based drug development","volume":"13","author":"Cui","year":"2024","journal-title":"Antibiotics: Basel"},{"issue":"9","key":"10.1016\/j.imj.2025.100168_bib0033","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/microorganisms11092311","article-title":"The biotechnological application of bacteriophages: what to do and where to go in the middle of the post-antibiotic era","volume":"11","author":"Jo","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.imj.2025.100168_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1136638","article-title":"An overview of the use of bacteriophages in the poultry industry: successes, challenges, and possibilities for overcoming breakdowns","volume":"14","author":"Abd-El Wahab","year":"2023","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/v11020096","article-title":"The preclinical and clinical progress of bacteriophages and their lytic enzymes: the parts are easier than the whole","volume":"11","author":"Abdelkader","year":"2019","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.imj.2025.100168_bib0036","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1007\/s00253-021-11695-z","article-title":"Phage therapeutics: from promises to practices and prospectives","volume":"105","author":"Bhargava","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0037","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.3390\/antibiotics8030131","article-title":"Phage therapy with a focus on the human microbiota","volume":"8","author":"Divya Ganeshan","year":"2019","journal-title":"Antibiotics: Basel"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered bacteriophage therapeutics: rationale, challenges and future","volume":"35","author":"\u0141obocka","year":"2021","journal-title":"BioDrugs"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0039","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrmicro3564","article-title":"A century of the phage: past, present and future","volume":"13","author":"Salmond","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"5\/6","key":"10.1016\/j.imj.2025.100168_bib0040","doi-asserted-by":"crossref","first-page":"e1294","DOI":"10.1093\/milmed\/usad385","article-title":"Disruption of biofilm by bacteriophages in clinically relevant settings","volume":"189","author":"Kovacs","year":"2024","journal-title":"Mil Med"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179245","article-title":"Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections","volume":"12","author":"Pallavali","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0042","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/microorganisms9071536","article-title":"Matrix-assisted laser desorption\/ionization time of flight mass spectrometry (MALDI-TOF MS) analysis for the identification of pathogenic microorganisms: a review","volume":"9","author":"Chen","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0043","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ph11010026","article-title":"Semi-solid and solid dosage forms for the delivery of phage therapy to epithelia","volume":"11","author":"Brown","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.imj.2025.100168_bib0044","doi-asserted-by":"crossref","first-page":"41441","DOI":"10.1038\/srep41441","article-title":"Microencapsulation with alginate\/CaCO3: a strategy for improved phage therapy","volume":"7","author":"Colom","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/pharmaceutics14020427","article-title":"Phages against pathogenic bacterial biofilms and biofilm-based infections: a review","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.imj.2025.100168_bib0046","doi-asserted-by":"crossref","first-page":"e18383","DOI":"10.1111\/jcmm.18383","article-title":"The use of phages for the biosynthesis of metal nanoparticles and their biological applications: a review","volume":"28","author":"Hosseininasab","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0047","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/ciy947","article-title":"A systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans","volume":"69","author":"El Haddad","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.imj.2025.100168_bib0048","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0049","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy","volume":"11","author":"Gill","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.imj.2025.100168_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmicb.2012.00238","article-title":"Phage therapy: concept to cure","volume":"3","author":"Keen","year":"2012","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0051","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"issue":"6969","key":"10.1016\/j.imj.2025.100168_bib0052","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nature02241","article-title":"SOS response promotes horizontal dissemination of antibiotic resistance genes","volume":"427","author":"Beaber","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0053","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0054","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.carbpol.2017.08.137","article-title":"Novel chitosan film embedded with liposome-encapsulated phage for biocontrol of Escherichia coli O157: H7 in beef","volume":"177","author":"Cui","year":"2017","journal-title":"Carbohydr Polym"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-6968.2009.01588.x","article-title":"Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity","volume":"295","author":"Mahichi","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.imj.2025.100168_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41538-023-00245-8","article-title":"Positive and negative aspects of bacteriophages and their immense role in the food chain","volume":"8","author":"Ranveer","year":"2024","journal-title":"NPJ Sci Food"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0057","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/AAC.00602-12","article-title":"Virulent bacteriophages can target O104: H4 enteroaggregative Escherichia coli in the mouse intestine","volume":"56","author":"Maura","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.imj.2025.100168_bib0058","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy","volume":"6","author":"Mattila","year":"2015","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0059","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/v10070351","article-title":"Resistance development to bacteriophages occurring during bacteriophage therapy","volume":"10","author":"Oechslin","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.imj.2025.100168_bib0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08927014.2013.779370","article-title":"Formation of biofilms under phage predation: considerations concerning a biofilm increase","volume":"29","author":"Hosseinidoust","year":"2013","journal-title":"Biofouling"},{"issue":"8","key":"10.1016\/j.imj.2025.100168_bib0061","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11274-014-1655-7","article-title":"Natural solution to antibiotic resistance: bacteriophages \u2018the living drugs","volume":"30","author":"Jassim","year":"2014","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0062","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/1040841X.2021.1962803","article-title":"Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies","volume":"48","author":"Ho","year":"2022","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0063","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1752-4571.2011.00236.x","article-title":"Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms","volume":"5","author":"Zhang","year":"2012","journal-title":"Evol Appl"},{"key":"10.1016\/j.imj.2025.100168_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1374466","article-title":"Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies","volume":"15","author":"Elfadadny","year":"2024","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4266\/acc.2023.01571","article-title":"Microbial infections in burn patients","volume":"39","author":"Roy","year":"2024","journal-title":"Acute Crit Care"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0066","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/sur.2013.134","article-title":"Infection in burns","volume":"17","author":"Norbury","year":"2016","journal-title":"Surg Infect: Larchmt"},{"key":"10.1016\/j.imj.2025.100168_bib0067","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.micres.2016.04.008","article-title":"Alternatives to overcoming bacterial resistances: state-of-the-art","volume":"191","author":"Rios","year":"2016","journal-title":"Microbiol Res"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0068","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.01028-06","article-title":"Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model","volume":"51","author":"McVay","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.imj.2025.100168_bib0069","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/D2MA00980C","article-title":"Advancements in bacteriophage therapies and delivery for bacterial infection","volume":"4","author":"Durr","year":"2023","journal-title":"Mater Adv"},{"key":"10.1016\/j.imj.2025.100168_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2016.00275","article-title":"CFTR modulators: shedding light on precision medicine for cystic fibrosis","volume":"7","author":"Lopes-Pacheco","year":"2016","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0071","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0072","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/mdr.2016.0048","article-title":"Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates","volume":"23","author":"Rutter","year":"2017","journal-title":"Microb Drug Resist"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0073","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.celrep.2019.01.071","article-title":"CFTR protects against Mycobacterium abscessus infection by fine-tuning host oxidative defenses","volume":"26","author":"Bernut","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.imj.2025.100168_bib0074","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.imj.2025.100168_bib0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"Law","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.imj.2025.100168_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.593988","article-title":"Overcoming challenges to make bacteriophage therapy standard clinical treatment practice for cystic fibrosis","volume":"11","author":"Ng","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1384164","article-title":"Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance","volume":"15","author":"Subramanian","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0078","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/326452","article-title":"Advances in bacteriophage-mediated control of plant pathogens","volume":"2012","author":"Frampton","year":"2012","journal-title":"Int J Microbiol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0079","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/pharmaceutics16030374","article-title":"Phage delivery strategies for biocontrolling human, animal, and plant bacterial infections: state of the art","volume":"16","author":"Vila","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0080","doi-asserted-by":"crossref","first-page":"qvae025","DOI":"10.1093\/sumbio\/qvae025","article-title":"Bacteriophages: sustainable and effective solution for climate-resilient agriculture","volume":"1","author":"Siyanbola","year":"2024","journal-title":"Sustain Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocontrol.2023.105375","article-title":"Assessing the environmental biosafety of phage-based biocontrol applications","volume":"187","author":"Fortuna","year":"2023","journal-title":"Biol Contr"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0082","article-title":"Phage therapy: targeting intestinal bacterial microbiota for the treatment of liver diseases","volume":"5","author":"Fujiki","year":"2023","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0083","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s44149-023-00065-z","article-title":"CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics","volume":"3","author":"Balcha","year":"2023","journal-title":"Anim Dis"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0084","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1039\/D3MA00817G","article-title":"Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects","volume":"5","author":"Emencheta","year":"2024","journal-title":"Mater Adv"},{"issue":"5","key":"10.1016\/j.imj.2025.100168_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/v10050218","article-title":"Framing the future with bacteriophages in agriculture","volume":"10","author":"Svircev","year":"2018","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.imj.2025.100168_bib0086","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/antibiotics10050559","article-title":"Phage therapy in livestock and companion animals","volume":"10","author":"Ferriol-Gonz\u00e1lez","year":"2021","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/j.imj.2025.100168_bib0087","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1073\/pnas.1218525110","article-title":"Animals in a bacterial world, a new imperative for the life sciences","volume":"110","author":"McFall-Ngai","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.imj.2025.100168_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.631794","article-title":"Animal models of phage therapy","volume":"12","author":"Penziner","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0089","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12866-024-03467-2","article-title":"Evaluation of lyophilized bacteriophage cocktail efficiency against multidrug-resistant Salmonella in broiler chickens","volume":"24","author":"Nabil","year":"2024","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0090","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1038\/s41598-023-38791-6","article-title":"Effects of bacteriophage on Salmonella enteritidis infection in broilers","volume":"13","author":"Sarrami","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0091","doi-asserted-by":"crossref","first-page":"15242","DOI":"10.1038\/s41598-019-51742-4","article-title":"Improved lyophilization conditions for long-term storage of bacteriophages","volume":"9","author":"Manohar","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0092","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/antibiotics9060301","article-title":"Growing trend of fighting infections in aquaculture environment-opportunities and challenges of phage therapy","volume":"9","author":"Kowalska","year":"2020","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0093","doi-asserted-by":"crossref","first-page":"16882","DOI":"10.1038\/s41598-024-67768-2","article-title":"Novel lytic bacteriophage AhFM11 as an effective therapy against hypervirulent Aeromonas hydrophila","volume":"14","author":"Muliya Sankappa","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.imj.2025.100168_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.753581","article-title":"Genistein inhibits the pathogenesis of Aeromonas hydrophila by disrupting quorum sensing mediated biofilm formation and aerolysin production","volume":"12","author":"Dong","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.imj.2025.100168_bib0095","unstructured":"Kutter E., Sulakvelidze A., Bacteriophages: Biology and Applications - Google Books. CRC Press, 2004. M12 28 - 528. https:\/\/books.google.com.bd\/books?hl=en&lr=&id=6sTBd2EJpmYC&oi=fnd&pg=PA91&dq=Sulakvelidze+et+al.,+2001a)+phage&ots=j29P0dk-jw&sig=LrJnI81f_WVethM7Iv2VtocRoVw&redir_esc=y#v=onepage&q=Sulakvelidzeetal.%2C2001a)phage&f=false (Accessed November 02, 2024)."},{"key":"10.1016\/j.imj.2025.100168_bib0096","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fmicb.2017.01108","article-title":"Bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the Enterobacteriaceae family - A review","volume":"8","author":"Colavecchio","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0097","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41426-018-0169-z","article-title":"The disparate effects of bacteriophages on antibiotic-resistant bacteria","volume":"7","author":"Torres-Barcel\u00f3","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.imj.2025.100168_bib0098","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1743-422X-10-100","article-title":"Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae","volume":"10","author":"K\u0119sik-Szeloch","year":"2013","journal-title":"Virol J"},{"issue":"7","key":"10.1016\/j.imj.2025.100168_bib0099","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/v13071268","article-title":"The safety and toxicity of phage therapy: a review of animal and clinical studies","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0100","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.tim.2024.05.005","article-title":"The growing repertoire of phage anti-defence systems","volume":"32","author":"Murtazalieva","year":"2024","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4172\/1747-0862.1000050","article-title":"The role of regulated clinical trials in the development of bacteriophage therapeutics","volume":"6","author":"Parracho","year":"2012","journal-title":"J Mol Genet Med"},{"issue":"33","key":"10.1016\/j.imj.2025.100168_bib0102","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1080\/10408398.2023.2254837","article-title":"Advanced strategies to overcome the challenges of bacteriophage-based antimicrobial treatments in food and agricultural systems","volume":"64","author":"Liu","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"10.1016\/j.imj.2025.100168_bib0103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.mib.2006.07.002","article-title":"The biological cost of mutational antibiotic resistance: any practical conclusions?","volume":"9","author":"Andersson","year":"2006","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0104","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41598-024-52192-3","article-title":"Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University","volume":"14","author":"W\u00fcrstle","year":"2024","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/14787210.2019.1694905","article-title":"Biological challenges of phage therapy and proposed solutions: a literature review","volume":"17","author":"Caflisch","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.imj.2025.100168_bib0106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s44259-024-00045-4","article-title":"Phage therapy could be key to conquering persistent bacterial lung infections in children","volume":"2","author":"Sithu Shein","year":"2024","journal-title":"NPJ Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/ph12010035","article-title":"Phages for phage therapy: isolation, characterization, and host range breadth","volume":"12","author":"Hyman","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0108","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0109","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2390720","article-title":"Role of bacteriophages in shaping gut microbial community","volume":"16","author":"Mahmud","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.imj.2025.100168_bib0110","article-title":"Gut phageome: challenges in research and impact on human microbiota","volume":"15","author":"Yu","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0111","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01258-23","article-title":"Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae","volume":"12","author":"Yoo","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/antibiotics10020145","article-title":"Pseudomonas aeruginosa resistance to bacteriophages and its prevention by strategic therapeutic cocktail formulation","volume":"10","author":"Vaitekenas","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.imj.2025.100168_bib0113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394805-2.00001-4","article-title":"Phage therapy pharmacology phage cocktails","volume":"78","author":"Chan","year":"2012","journal-title":"Adv Appl Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920110790725348","article-title":"Designing phage therapeutics","volume":"11","author":"Goodridge","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.imj.2025.100168_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.coviro.2021.12.003","article-title":"Engineering therapeutic phages for enhanced antibacterial efficacy","volume":"52","author":"Meile","year":"2022","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0116","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/v5030806","article-title":"Understanding bacteriophage specificity in natural microbial communities","volume":"5","author":"Koskella","year":"2013","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0117","doi-asserted-by":"crossref","first-page":"e3957","DOI":"10.1371\/journal.pone.0003957","article-title":"BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes","volume":"3","author":"Marinelli","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.imj.2025.100168_bib0118","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/v15081736","article-title":"Genetic engineering and biosynthesis technology: keys to unlocking the chains of phage therapy","volume":"15","author":"Lv","year":"2023","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.imj.2025.100168_bib0119","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/AEM.71.8.4872-4874.2005","article-title":"Escherichia coli K1\u2019s capsule is a barrier to bacteriophage T7","volume":"71","author":"Scholl","year":"2005","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jbiotec.2004.08.003","article-title":"Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157: H7","volume":"115","author":"Yoichi","year":"2005","journal-title":"J Biotechnol"},{"key":"10.1016\/j.imj.2025.100168_bib0121","series-title":"Bacteriophages","article-title":"Temperate phages, prophages, and lysogeny","author":"\u0141o\u015b","year":"2021"},{"key":"10.1016\/j.imj.2025.100168_bib0122","first-page":"173","article-title":"Phage therapy: a different approach to fight bacterial infections","volume":"16","author":"Hibstu","year":"2022","journal-title":"Biologics"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0123","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.imj.2025.100168_bib0124","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.imj.2025.100168_bib0125","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1093\/cid\/ciad539","article-title":"Knowing and Naming: phage annotation and nomenclature for phage therapy","volume":"77","author":"Grigson","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.102949","article-title":"Protocol for phage matching, treatment, and monitoring for compassionate bacteriophage use in non-resolving infections","volume":"5","author":"Onallah","year":"2024","journal-title":"STAR Protoc"},{"issue":"9","key":"10.1016\/j.imj.2025.100168_bib0127","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-022-00806-1","article-title":"Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far","volume":"29","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.imj.2025.100168_bib0129","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.imj.2025.100168_bib0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","article-title":"Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model","volume":"25","author":"Hsu","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.imj.2025.100168_bib0131","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1574-6976.12072","article-title":"Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities","volume":"38","author":"Koskella","year":"2014","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0132","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/antibiotics10020209","article-title":"Rapid methods for antimicrobial resistance diagnostics","volume":"10","author":"Kaprou","year":"2021","journal-title":"Antibiotics"},{"issue":"12","key":"10.1016\/j.imj.2025.100168_bib0133","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/jobm.202100201","article-title":"Antibiotic resistance genes in bacteria: occurrence, spread, and control","volume":"61","author":"Jian","year":"2021","journal-title":"J Basic Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0134","doi-asserted-by":"crossref","first-page":"dlae017","DOI":"10.1093\/jacamr\/dlae017","article-title":"Improving phage therapy by evasion of phage resistance mechanisms","volume":"6","author":"Bleriot","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.imj.2025.100168_bib0135","article-title":"Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics","volume":"85","author":"Samananda","year":"2024","journal-title":"Biologicals"},{"issue":"10","key":"10.1016\/j.imj.2025.100168_bib0136","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.3390\/ijms25105465","article-title":"Current knowledge and perspectives of phage therapy for combating refractory wound infections","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.imj.2025.100168_bib0137","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.584137","article-title":"Editorial: manufacturing, formulation and delivery issues for phage therapy to become a reality","volume":"11","author":"Malik","year":"2020","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.imj.2025.100168_bib0138","first-page":"e17744","article-title":"Effective phages as green antimicrobial agents against antibiotic-resistant hospital Escherichia coli","volume":"8","author":"Rahmani","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0139","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fmicb.2018.00561","article-title":"Liposome entrapment of bacteriophages improves wound healing in a diabetic mouse MRSA infection","volume":"9","author":"Chhibber","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AEM.00785-09","article-title":"Phage therapy to reduce preprocessing Salmonella infections in market-weight swine","volume":"76","author":"Wall","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.imj.2025.100168_bib0141","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fmicb.2016.00279","article-title":"Characterization of novel bacteriophages for biocontrol of bacterial blight in leek caused by Pseudomonas syringae pv. porri","volume":"7","author":"Rombouts","year":"2016","journal-title":"Front Microbiol"},{"issue":"27","key":"10.1016\/j.imj.2025.100168_bib0142","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1080\/10408398.2022.2059442","article-title":"Bacteriophage and endolysin engineering for biocontrol of food pathogens\/pathogens in the food: recent advances and future trends","volume":"63","author":"Lee","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0143","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/ppa.12417","article-title":"Development of a tomato plant resistant to Clavibacter michiganensis using the endolysin gene of bacteriophage CMP1 as a transgene","volume":"65","author":"Wittmann","year":"2016","journal-title":"Plant Pathol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0144","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/v9030050","article-title":"A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms","volume":"9","author":"Doss","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imj.2025.100168_bib0145","first-page":"346","article-title":"Treating bacterial infections with bacteriophages in the 21st century","volume":"37","author":"Opperman","year":"2022","journal-title":"S Afr J Infect Dis"},{"issue":"15","key":"10.1016\/j.imj.2025.100168_bib0146","doi-asserted-by":"crossref","first-page":"e35666","DOI":"10.1016\/j.heliyon.2024.e35666","article-title":"Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria","volume":"10","author":"Eghbalpoor","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.imj.2025.100168_bib0147","doi-asserted-by":"crossref","unstructured":"Li X.H., He Y.H., Wang Z.L., et al. A combination therapy of phages and antibiotics: two is better than one. Int J Biol Sci., 17(13): 3573\u20133582. doi:10.7150\/ijbs.60551.","DOI":"10.7150\/ijbs.60551"},{"key":"10.1016\/j.imj.2025.100168_bib0148","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.copbio.2021.03.002","article-title":"Preclinical data and safety assessment of phage therapy in humans","volume":"68","author":"Nale","year":"2021","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.imj.2025.100168_bib0149","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1042\/BST20231289","article-title":"Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy","volume":"52","author":"Lewis","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.imj.2025.100168_bib0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s13205-024-04101-8","article-title":"Phage therapy: a novel approach against multidrug-resistant pathogens","volume":"14","author":"Kapoor","year":"2024","journal-title":"3 Biotech"}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:09:05Z","timestamp":1744999745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X25000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2772431X25000073"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2025.100168","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2025.100168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100168"}}